Iqra Kanwal, Hunain Ali, Farkhanda Mushtaq, Sadia Basharat Ali, A. Ganesan, Shabana Usman Simjee, Muhammad Adnan Akram, Farzana Shaheen
{"title":"Synthesis of a Trans-Phakellistatin 21/22 Conformer and Related Alanine Scanning Analogs With Neuroprotective Activity","authors":"Iqra Kanwal, Hunain Ali, Farkhanda Mushtaq, Sadia Basharat Ali, A. Ganesan, Shabana Usman Simjee, Muhammad Adnan Akram, Farzana Shaheen","doi":"10.1002/psc.70018","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>The phakellistatins are a class of cyclic peptide natural products among which phakellistatin 21 and 22 isolated from the marine sponge <i>Stylissa flabelliformis</i> are <i>cyclo</i>(Pro<sup>1</sup>-Pro<sup>2</sup>-Met(O)<sup>3</sup>-Phe<sup>4</sup>-Glu<sup>5</sup>-Leu<sup>6</sup>-Pro<sup>7</sup>-Pro<sup>8</sup>-Tyr<sup>9</sup>-Ile<sup>10</sup>) epimeric at the methionine sulfoxide residue. The natural product contains two <i>cis</i> and two <i>trans</i> proline residues and is reported to have significant cytotoxic activities. We attempted the total synthesis of phakellistatin 21/22 via on-resin macrocyclization using methionine as a building block. The final product contained methionine sulfoxide, suggesting that aerial oxidation took place during the synthesis and during the original isolation of the natural product. Our synthetic peptide <i>cyclo</i>(<i>trans-Pro</i><sup><i>1,2,7,8</i></sup><i>)</i>-Pha21 (1) was identified as an unnatural conformer of natural product phakellistatin 21/22 with all Pro residues present as <i>trans</i> amides. The Peptide 1 was inactive against human cancer cell lines, unlike the natural product. We additionally synthesized alanine scanning Analogs 2–5 in which a Pro residue was replaced by Ala and Analog 6, where all four Pro residues were substituted by Ala. Peptides 1, 2, 3, and 5 were found to have neuroprotective effects on primary cortex cells and are potential leads for the treatment of neurodegenerative disorders.</p>\n </div>","PeriodicalId":16946,"journal":{"name":"Journal of Peptide Science","volume":"31 5","pages":""},"PeriodicalIF":1.8000,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Peptide Science","FirstCategoryId":"99","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/psc.70018","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The phakellistatins are a class of cyclic peptide natural products among which phakellistatin 21 and 22 isolated from the marine sponge Stylissa flabelliformis are cyclo(Pro1-Pro2-Met(O)3-Phe4-Glu5-Leu6-Pro7-Pro8-Tyr9-Ile10) epimeric at the methionine sulfoxide residue. The natural product contains two cis and two trans proline residues and is reported to have significant cytotoxic activities. We attempted the total synthesis of phakellistatin 21/22 via on-resin macrocyclization using methionine as a building block. The final product contained methionine sulfoxide, suggesting that aerial oxidation took place during the synthesis and during the original isolation of the natural product. Our synthetic peptide cyclo(trans-Pro1,2,7,8)-Pha21 (1) was identified as an unnatural conformer of natural product phakellistatin 21/22 with all Pro residues present as trans amides. The Peptide 1 was inactive against human cancer cell lines, unlike the natural product. We additionally synthesized alanine scanning Analogs 2–5 in which a Pro residue was replaced by Ala and Analog 6, where all four Pro residues were substituted by Ala. Peptides 1, 2, 3, and 5 were found to have neuroprotective effects on primary cortex cells and are potential leads for the treatment of neurodegenerative disorders.
期刊介绍:
The official Journal of the European Peptide Society EPS
The Journal of Peptide Science is a cooperative venture of John Wiley & Sons, Ltd and the European Peptide Society, undertaken for the advancement of international peptide science by the publication of original research results and reviews. The Journal of Peptide Science publishes three types of articles: Research Articles, Rapid Communications and Reviews.
The scope of the Journal embraces the whole range of peptide chemistry and biology: the isolation, characterisation, synthesis properties (chemical, physical, conformational, pharmacological, endocrine and immunological) and applications of natural peptides; studies of their analogues, including peptidomimetics; peptide antibiotics and other peptide-derived complex natural products; peptide and peptide-related drug design and development; peptide materials and nanomaterials science; combinatorial peptide research; the chemical synthesis of proteins; and methodological advances in all these areas. The spectrum of interests is well illustrated by the published proceedings of the regular international Symposia of the European, American, Japanese, Australian, Chinese and Indian Peptide Societies.